Stock A237690 ST PHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News ST Pharm Co.,Ltd.

Equities

A237690

KR7237690003

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-19 pm EDT 		5-day change 1st Jan Change
100,000 KRW -1.77% Intraday chart for ST Pharm Co.,Ltd. +9.65% +47.49%
2023 ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2021 ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility
CI
Samsung Biologics : S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
RE
Market Chatter: ST Pharm to Launch mRNA-based COVID-19 Vaccine in 2022
MT
ST Pharm Co.,Ltd. announced that it has received KRW 110 billion in funding
CI
ST Pharm Co.,Ltd. announced that it expects to receive KRW 110 billion in funding
CI
Avidity Biosciences, Inc. announced that it has received $78.999943 million in funding from Alethea Capital Management, LLC, Alexandria Venture Investments, LLC, Takeda Ventures, Inc., CureDuchenne Ventures LLC, ST Pharm Co.,Ltd.
CI
ST Pharm Co.,Ltd. acquired 70% stake in AnaPath GmbH.
CI
Avidity Biosciences, Inc. announced that it expects to receive $76.699946 million in funding from Alethea Capital Management, LLC, Alexandria Venture Investments, LLC, Takeda Ventures, Inc., CureDuchenne Ventures LLC, ST Pharm Co.,Ltd.
CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of an additional stake in ST Pharm Co. Ltd..
CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd..
CI
ST Pharm Co.,Ltd. cancelled the acquisition of Banwol Factory from Dong-A ST Co., Ltd..
CI
ST Pharm Co. Ltd.(KOSDAQ:A237690) added to S&P Global BMI Index
CI
Dong-A Socio Holdings Co. Ltd. made a tender offer to acquire an additional stake in ST Pharm Co. Ltd. for approximately KRW 170 million.
CI
ST Pharm Co. Ltd. has completed an IPO in the amount of KRW 135.26 billion.
CI
ST Pharm Co. Ltd. has filed an IPO.
CI
Dong-A Socio Holdings Co. Ltd. agreed to acquire additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd. for KRW 25.9 billion.
CI
ST Pharm Co.,Ltd. agreed to acquire Banwol Factory from Dong-A ST Co., Ltd. for KRW 51 billion.
CI
Dong-A Socio Holdings Co. Ltd. completed the acquisition of additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others.
CI
Dong-A Socio Holdings Co. Ltd. made an offer to acquire additional 2.7% stake in Dong-A ST Co.,Ltd from Jung-Seok Kang, ST Pharm Co. Ltd., Sangju Academy and others for KRW 19.9 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A237690 Stock
  4. News ST Pharm Co.,Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW